Stocks-NUWE-Nuwellis Inc

NUWE Nuwellis Inc

8.55 0.10 (1.18%)
Delayed Prices By NASDAQ, in USD Market Closed
Invest

About Nuwellis Inc

Nuwellis Inc is a global medical device company engaged in the development and commercialisation of life-changing solutions for patients who suffer from fluid overload. Established in 2002, the firm is headquartered in Eden Prairie, Minnesota, and operates internationally. The firm’s products include the Aquadex SmartFlow System, which is clinically proven to simply, safely, and precisely remove excess fluids from the body in patients who suffer from fluid overload and who have not responded to other medical solutions for their condition, including diuretics. The Aquadex SmartFlow System can remove up to 500ml excess fluid hourly and has no significant negative impact on health indicators such as blood pressure and heart rate. Nuwellis Inc is positively impacting patients with lightweight, portable, versatile devices, which can be highly automated and administer therapy though either peripheral or central venous access. Previously known as CHF Solutions, the firm changed its name and rebranded in 2021. Later that year, Nuwellis Inc announced its IPO, launching on the NASDAQ in September 2021. The firm publicly trades under the stock ticker NUWE. Start monitoring the Nuwellis Inc share price by adding this stock to your eToro watchlist to get instant news and updates on NUWE stock value changes.
70
Employees
Eden Prairie, Minnesota, US
HQ
1999
Founded
Nestor Jaramillo, Jr., MBA
CEO
Show More

Upcoming Earnings

28
FEB
REPORTS
Nuwellis Inc Q4 2022 earnings report is expected to be released before market open

People Also Bought